Trending NewsTrending NewsNYSE:JNJ Johnson & Johnson (JNJ) Stock Price, News & Analysis $267.02 -5.68 (-2.08%) Closing price 11/19/2026 03:59 PM EasternExtended Trading$270.79 +3.77 (+1.41%) As of 04:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Johnson & Johnson Stock (NYSE:JNJ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Johnson & Johnson alerts:Sign Up Key Stats Today's Range$264.68▼$270.6050-Day Range$248.90▼$285.7852-Week Range$199.90▼$290.25Volume9.84 million shsAverage Volume7.56 million shsMarket Capitalization$642.80 billionP/E Ratio40.46Dividend Yield2.01%Price Target$275.92Consensus RatingModerate Buy Company Overview Johnson & Johnson is a global healthcare company that develops and sells prescription medicines and medical technologies. Its business is organized around two segments: Innovative Medicine and MedTech. Innovative Medicine develops treatments in areas including oncology, immunology, neuroscience, cardiovascular and metabolic disease, and pulmonary hypertension. MedTech provides products and technologies for fields such as surgery, orthopedics, and vision care. Founded in 1886, Johnson & Johnson serves patients and healthcare professionals in markets around the world. The company is headquartered in New Brunswick, New Jersey, and is led by Chairman and Chief Executive Officer Joaquin Duato.AI Generated. May Contain Errors. Read More Johnson & Johnson Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreJNJ MarketRank™: 3.3500756846 of 5 starsJohnson & Johnson scored higher than 67% of companies evaluated by MarketBeat, and ranked 231st out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.6 / 5Analyst RatingModerate Buy Consensus RatingJohnson & Johnson has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 17 buy ratings, 8 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Johnson & Johnson is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageJohnson & Johnson has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Johnson & Johnson's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth3.60% Earnings GrowthEarnings for Johnson & Johnson are expected to grow by 3.60% in the coming year, from $11.12 to $11.52 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Johnson & Johnson is 40.46, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.43.Price to Earnings Ratio vs. SectorThe P/E ratio of Johnson & Johnson is 40.46, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.10.Price to Earnings Growth RatioJohnson & Johnson has a PEG Ratio of 2.74. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioJohnson & Johnson has a P/B Ratio of 7.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Johnson & Johnson's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.71% of the float of Johnson & Johnson has been sold short.Short Interest Ratio / Days to CoverJohnson & Johnson has a short interest ratio ("days to cover") of 2.41, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Johnson & Johnson has recently increased by 1.80%, indicating that investor sentiment is decreasing. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldJohnson & Johnson pays a meaningful dividend of 1.97%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthJohnson & Johnson has been increasing its dividend for 64 years.Dividend CoverageThe dividend payout ratio of Johnson & Johnson is 81.21%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Johnson & Johnson will have a dividend payout ratio of 46.53% next year. This indicates that Johnson & Johnson will be able to sustain or increase its dividend.Read more about Johnson & Johnson's dividend. News and Social Media4.1 / 5News Sentiment0.58 News SentimentJohnson & Johnson has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 79 news articles for Johnson & Johnson this week, compared to 9 articles on an average week.Search Interest103 people have searched for JNJ on MarketBeat in the last 30 days. This is an increase of 23% compared to the previous 30 days.MarketBeat Follows57 people have added Johnson & Johnson to their MarketBeat watchlist in the last 30 days. This is an increase of 39% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Johnson & Johnson insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,947,986.00 in company stock.Percentage Held by Insiders0.16% of the stock of Johnson & Johnson is held by insiders.Percentage Held by Institutions69.55% of the stock of Johnson & Johnson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Johnson & Johnson's insider trading history. Receive JNJ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JNJ Stock News HeadlinesJohnson & Johnson Delivered 'Immaculate' Prostate Cancer Data at ESMO. Here's Why Investors Should CareNovember 19 at 8:15 PM | fool.comJohnson & Johnson Delivered 'Immaculate' Prostate Cancer Data at ESMO. Here's Why Investors Should CareNovember 19 at 7:11 PM | fool.comGet your evenings backThe Instant Scanner delivers the night's qualifying setups with exact buy prices and defined exits, in minutes. No hours of flipping through charts, no second-guessing patterns. It's built for traders who want the result without the ritual: a short list and your evening back. Black Friday price is $7 versus the regular $247. One payment covers a full year, with no re-bills. | Profits Run (Ad)3 Dow Dividend Passive Income Stocks for Retirement, Led by a 64-Year StreakNovember 19 at 3:32 PM | 247wallst.comWant Reliable Retirement Income? Invest in These 3 Dow Jones Passive Income Dividend StocksNovember 19 at 3:08 PM | 247wallst.comJohnson & Johnson (NYSE:JNJ) EVP Elizabeth Forminard Sells 13,072 Shares of Company StockNovember 15, 2026 | insidertrades.comThe AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom (JNJ)AI infrastructure is being funded with debt and stock sales while biotech companies applying AI are booking revenue, led by Tempus AI, Recursion and iShares Biotechnology...November 11, 2026 | marketbeat.com5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps (JNJ)Teradyne, Grail, Kratos Defense, FormFactor and Fabrinet have pulled back despite strong growth, setting up potential entry points in robotics, quantum and AI.October 26, 2026 | marketbeat.comSee More Headlines JNJ Stock Analysis - Frequently Asked Questions How have JNJ shares performed this year? Johnson & Johnson's stock was trading at $207.07 at the beginning of the year. Since then, JNJ stock has increased by 29.0% and is now trading at $267.02. How were Johnson & Johnson's earnings last quarter? Johnson & Johnson (NYSE:JNJ) announced its quarterly earnings results on Tuesday, October, 13th. The company reported $2.59 EPS for the quarter, topping the consensus estimate of $2.53 by $0.06. The firm's quarterly revenue was up 5.9% compared to the same quarter last year. Read the conference call transcript. Does Johnson & Johnson have any subsidiaries? Johnson & Johnson subsidiaries include Momenta Pharmaceuticals, TARIS Biomedical, Verb Surgical, Auris Health, Ci:z Holdings, Zarbee's Naturals, Orthotaxy, and others. Who are Johnson & Johnson's major shareholders? Top institutional investors of Johnson & Johnson include State Street Corp (5.57%), Fisher Asset Management LLC (0.62%), HighTower Advisors LLC (0.41%) and Ninety One UK Ltd (0.27%). Insiders that own company stock include & Johnson Johnson, Jennifer L Taubert, Kathryn E Wengel, Timothy Schmid, Vanessa Broadhurst, Robert J Decker, Elizabeth Forminard and Mark A Weinberger. View institutional ownership trends. How do I buy shares of Johnson & Johnson? Shares of JNJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Johnson & Johnson own? Based on aggregate information from My MarketBeat watchlists, some other companies that Johnson & Johnson investors own include NVIDIA (NVDA), Pfizer (PFE), JPMorgan Chase & Co. (JPM), AbbVie (ABBV), Walmart (WMT), Procter & Gamble (PG) and AT&T (T). Company Calendar Record date for 9/8 Dividend8/25/2026Ex-Dividend for 9/8 Dividend8/25/2026Dividend Payable9/08/2026Last Earnings10/13/2026Today11/20/2026Record date for 12/8 Dividend11/24/2026Ex-Dividend for 12/8 Dividend11/24/2026Dividend Payable12/08/2026Investor update12/08/2026Fiscal Year End12/31/2026Next Earnings (Estimated)1/26/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 JNJ's financial health is in the Green zone, according to TradeSmith. JNJ has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:JNJ CIK200406 Webwww.jnj.com Phone(732) 524-0400Fax732-214-0332Employees138,200Year Founded1886Price Target and Rating Average Price Target for Johnson & Johnson$275.92 High Price Target$320.00 Low Price Target$210.00 Potential Upside/Downside+3.3%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage26 Analysts Profitability EPS (Trailing Twelve Months)$6.60 Trailing P/E Ratio40.46 Forward P/E Ratio23.18 P/E Growth2.74Net Income$26.80 billion Net Margins16.20% Pretax Margin17.86% Return on Equity31.64% Return on Assets13.04% Debt Debt-to-Equity Ratio0.44 Current Ratio1.02 Quick Ratio0.74 Sales & Book Value Annual Sales$94.19 billion Price / Sales6.82 Cash Flow$13.83 per share Price / Cash Flow19.31 Book Value$33.87 per share Price / Book7.88Miscellaneous Outstanding Shares2,407,310,000Free Float2,403,458,000Market Cap$642.80 billion OptionableOptionable Beta0.22 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:JNJ) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.